Evaluate the efficacy of hydroxychloroquine in the prevention of SARS-COV2 infection in high risk health care workers

Not Applicable

Recruiting

• Conditions: COVID-19.; covid-19; U07.1

• Registration Number: IRCT20200414047076N1
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 August 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 160

Inclusion Criteria

Signing the consent form of high-risk personnel and exposed to the virus

Exclusion Criteria

Treatment with other antiviral drugs at the same time, except for the drugs prescribed in the national protocol
Concomitant diseases: malignancy, advanced heart failure, cirrhosis, people under dialysis, stroke, Alzheimer's, progressive chronic neurological diseases
Evidence of multi-organ failure
Pregnancy or lactation

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The onset of covid-19 infection. Timepoint: Before study and after 3 and 6 months. Method of measurement: Clinical symptoms, Corona PCR, CT scan of the lungs.

Secondary Outcome Measures

Name	Time	Method
The severity of COVID-19. Timepoint: Before study and after 3 and 6 months. Method of measurement: Clinical feature, CT scan.